methyl 2-ethyl-2,5,7,12-tetrahydroxy-4,6,11-trioxo-1,2,3-trihydronaphthacenecarboxylate

ID: ALA388565

Chembl Id: CHEMBL388565

PubChem CID: 14524973

Max Phase: Preclinical

Molecular Formula: C22H18O9

Molecular Weight: 426.38

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Synonyms: maggiemycin | Maggiemycin|methyl 2-ethyl-2,5,7,12-tetrahydroxy-4,6,11-trioxo-1,3-dihydrotetracene-1-carboxylate|CHEMBL388565|SCHEMBL4384777|CHEBI:205824|FCUPTGDGQULLKX-UHFFFAOYSA-N

Canonical SMILES:  CCC1(O)CC(=O)c2c(O)c3c(c(O)c2C1C(=O)OC)C(=O)c1cccc(O)c1C3=O

Standard InChI:  InChI=1S/C22H18O9/c1-3-22(30)7-10(24)12-13(16(22)21(29)31-2)20(28)14-15(19(12)27)18(26)11-8(17(14)25)5-4-6-9(11)23/h4-6,16,23,27-28,30H,3,7H2,1-2H3

Standard InChI Key:  FCUPTGDGQULLKX-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA388565

    MAGGIEMYCIN

Associated Targets(Human)

ITGA2 Tbio Integrin alpha-2 (11 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CHO (4503 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 426.38Molecular Weight (Monoisotopic): 426.0951AlogP: 1.56#Rotatable Bonds: 2
Polar Surface Area: 158.43Molecular Species: NEUTRALHBA: 9HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 7.42CX Basic pKa: CX LogP: 4.01CX LogD: 3.68
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.35Np Likeness Score: 1.47

References

1. Käpylä J, Pentikäinen OT, Nyrönen T, Nissinen L, Lassander S, Jokinen J, Lahti M, Marjamäki A, Johnson MS, Heino J..  (2007)  Small molecule designed to target metal binding site in the alpha2I domain inhibits integrin function.,  50  (11): [PMID:17447751] [10.1021/jm070063t]

Source